CD8A and cancer: Stem-like CD8+ T cells are present not only during chronic infection but also in human cancers (13–18), and PD-1 blockade increases the number of effector-like transitory T cells by promoting the differentiation of stem-like T cells toward the TIM3+ state (6, 19, 20).